359 related articles for article (PubMed ID: 15352906)
1. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease.
Winter J; Walker A; Shapiro D; Gaffney D; Spooner RJ; Mills PR
Aliment Pharmacol Ther; 2004 Sep; 20(6):593-9. PubMed ID: 15352906
[TBL] [Abstract][Full Text] [Related]
2. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
Marra CA; Esdaile JM; Anis AH
J Rheumatol; 2002 Dec; 29(12):2507-12. PubMed ID: 12465143
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of thiopurine methyltransferase genotype screening in IBD.
Kitiyakara T; Hayat J; McIntyre AS
Aliment Pharmacol Ther; 2005 Mar; 21(6):790-1; author reply 791-2. PubMed ID: 15771767
[No Abstract] [Full Text] [Related]
4. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
6. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
Winter JW; Gaffney D; Shapiro D; Spooner RJ; Marinaki AM; Sanderson JD; Mills PR
Aliment Pharmacol Ther; 2007 May; 25(9):1069-77. PubMed ID: 17439508
[TBL] [Abstract][Full Text] [Related]
7. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients.
Gazouli M; Pachoula I; Panayotou I; Mantzaris G; Syriopoulou VP; Goutas N; Vlachodimitropoulos D; Anagnou NP; Roma-Giannikou E
J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
Kwan LY; Devlin SM; Mirocha JM; Papadakis KA
Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea.
Oh KT; Anis AH; Bae SC
Rheumatology (Oxford); 2004 Feb; 43(2):156-63. PubMed ID: 12923290
[TBL] [Abstract][Full Text] [Related]
11. Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.
Tavadia SM; Mydlarski PR; Reis MD; Mittmann N; Pinkerton PH; Shear N; Sauder DN
J Am Acad Dermatol; 2000 Apr; 42(4):628-32. PubMed ID: 10727309
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
Gearry RB; Barclay ML
J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
[TBL] [Abstract][Full Text] [Related]
13. Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
Hindorf U; Lindqvist M; Hildebrand H; Fagerberg U; Almer S
Aliment Pharmacol Ther; 2006 Jul; 24(2):331-42. PubMed ID: 16842460
[TBL] [Abstract][Full Text] [Related]
14. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
Dubinsky MC; Reyes E; Ofman J; Chiou CF; Wade S; Sandborn WJ
Am J Gastroenterol; 2005 Oct; 100(10):2239-47. PubMed ID: 16181376
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
16. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
Aghdaie MH; Azarpira N; Geramizadeh B; Sagheb M; Darai M; Rahsaz M; Malekhoseini SA
Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?
Bourgine J; Garat A; Allorge D; Crunelle-Thibaut A; Lo-Guidice JM; Colombel JF; Broly F; Billaut-Laden I
Pharmacogenet Genomics; 2011 Jun; 21(6):313-24. PubMed ID: 21372752
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease.
Van Dieren JM; Hansen BE; Kuipers EJ; Nieuwenhuis EE; Van der Woude CJ
Aliment Pharmacol Ther; 2007 Sep; 26(5):643-52. PubMed ID: 17697198
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the TPMT gene in the Czech healthy population and patients with inflammatory bowel disease.
Slanar O; Bortlík M; Buzková H; Donoval R; Pechandová K; Sebesta I; Lukás M; Perlík F
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):835-8. PubMed ID: 18600549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
